pPB-PGK-destination Citations (2)
Originally described in: Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human.Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A Cell. 2014 Sep 11;158(6):1254-69. doi: 10.1016/j.cell.2014.08.029. PubMed Journal
Articles Citing pPB-PGK-destination
Articles |
---|
Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream. Neumeyer J, Lin RZ, Wang K, Hong X, Hua T, Croteau SE, Neufeld EJ, Melero-Martin JM. Blood Adv. 2019 Dec 23;3(24):4166-4176. doi: 10.1182/bloodadvances.2019000848. PubMed |
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S. Nat Commun. 2023 Apr 13;14(1):2109. doi: 10.1038/s41467-023-37727-y. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.